StockData
Integra LifeSciences Holdings Corp logo

Integra LifeSciences Holdings Corp (IART) stock

IARTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 9/308% below fair value
$13.86+0.31 (+2.29%)

Close on Nov 18, 2026Market cap $1.08BP/E 81.5Yield –

Integra LifeSciences market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Integra LifeSciences's market cap was $1.14B on Nov 11, 2026, against $1.00B a year earlier. Over the last 5 years it ranged from $722.25M to $5.73B, with a median of $2.34B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.14B+19.8%
2025Dec 31, 2025$951.26M-45.8%
2024Dec 31, 2024$1.76B-50.7%
2023Dec 29, 2023$3.56B-24.7%
2022Dec 30, 2022$4.72B-17.3%
2021Dec 31, 2021$5.71B+3.0%
2020Dec 31, 2020$5.54B+10.4%
2019Dec 31, 2019$5.02B+35.3%
2018Dec 31, 2018$3.71B-2.2%
2017Dec 29, 2017$3.80B+10.8%
2016Dec 30, 2016$3.43B+48.8%
2015Dec 31, 2015$2.30B+44.3%
2014Dec 31, 2014$1.60B+32.1%
2013Dec 31, 2013$1.21B+19.9%
2012Dec 31, 2012$1.01B+21.2%
2011Dec 30, 2011$831.45M-35.2%
2010Dec 31, 2010$1.28B+35.5%
2009Dec 31, 2009$946.02M–

More Integra LifeSciences figures

See a number that looks wrong?